Immunoavidity-Based Capture of Tumor Exosomes Using Poly(amidoamine) Dendrimer Surfaces

Tumor-derived blood-circulating exosomes have potential as a biomarker to greatly improve cancer treatment. However, effective isolation of exosomes remains a tremendous technical challenge. This study presents a novel nanostructured polymer surface for highly effective capture of exosomes through strong avidity. Various surface configurations, consisting of multivalent dendrimers, PEG, and tumor-targeting antibodies, were tested using exosomes isolated from tumor cell lines. We found that a dual layer dendrimer configuration exhibited the highest efficiency in capturing cultured exosomes spiked into human serum. Importantly, the optimized surface captured a > 4-fold greater amount of tumor exosomes from head and neck cancer patient plasma samples than that from healthy donors. Nanomechanical analysis using atomic force microscopy also revealed that the enhancement was attributed to multivalent binding (avidity) and augmented short-range adhesion mediated by dendrimers. Our results support that the dendrimer surface detects tumor exosomes at high sensitivity and specificity, demonstrating its potential as a new cancer liquid biopsy platform.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:20

Enthalten in:

Nano letters - 20(2020), 8 vom: 12. Aug., Seite 5686-5692

Sprache:

Englisch

Beteiligte Personen:

Poellmann, Michael J [VerfasserIn]
Nair, Ashita [VerfasserIn]
Bu, Jiyoon [VerfasserIn]
Kim, Jack K H [VerfasserIn]
Kimple, Randall J [VerfasserIn]
Hong, Seungpyo [VerfasserIn]

Links:

Volltext

Themen:

Biomarker
Dendrimers
Exosome
Extracellular vesicle
Journal Article
Multivalent binding
Poly(amidoamine)
Poly(amidoamine) dendrimer
Polyamines
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

Anmerkungen:

Date Completed 24.06.2021

Date Revised 24.06.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.nanolett.0c00950

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM309899311